This clinical trial is not currently recruiting participants. To find active clinical trials similar to this one please visit Clinical Trials Search. To be notified of new clinical trials as they become available visit Free Member Signup.

Study summary

<b>Atopic Dermatitis (Eczema) - Multiple Locations in the US</b>

    Eczema Study for Kids and Adults: The ADORING study is evaluating an investigational non-steroidal topical cream for people aged 2 years and older who suffer from moderate to severe eczema, also known as atopic dermatitis (AD).

    ADORING is a phase 3 clinical study evaluating the safety and efficacy of tapinarof cream, 1% for the topical treatment of moderate to severe eczema in adults and children aged 2 years and above.

    ADORING at a Glance

    • Participants: up to 400 adults and children
    • Duration: up to 13 weeks
    • Administration: daily self-application of cream

    People who may be eligible:*

    • Been diagnosed with eczema
      • for at least 6 months for those 6 years old and above or
      • 3 months for those 2 to 5 years old
    • Male or female, 2 years of age or older
    • Have eczema that covers between 5% and 35% of their body, not including the scalp. NOTE: Participants with eczema only on their palms and soles are not eligible.

    *Other criteria will apply To learn more and find out if you or your child may be eligible, please CLICK HERE.

    Study is available at

    This study is being conducted NATIONWIDE! To find clinics conducting this study near you please use search feature below.

    Study Locations